Phase II Single-Arm Trial Of CPT-11 (Irinotecan HC1; Camptosar Injection)/Cisplatin In Patients With Advanced Esophageal Cancer
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Cisplatin (Primary) ; Irinotecan (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 22 Dec 2009 Actual end date (Dec 2003) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2005 New trial record.